As per the Regulation 32 of SEBI(LODR) of Regulation ,2015 ( statement of Deviation or Variation for proceeds of Public issue , rights,(QIP) , is not applicable to the Company for the Quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd has informed BSE that Regulation 32 of SEBI (LODR) Regulations, 2015 — which requires companies to report any deviation or variation in the use of proceeds from public issues, rights issues, preferential issues, or QIPs — is not applicable to the company for the quarter ended 31st March 2025. The reason given is that the company has not undertaken any public issue, rights issue, preferential issue, or Qualified Institutional Placement (QIP) during the period. The letter is signed by Dr. L.S., Director & Company Secretary (DIN: 00825886), dated 2nd April 2025.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company did not raise funds through any of the specified routes during the quarter, so no deviation report is required.